It is also appropriate to limit, following confirmation of the presence of a transmissible spongiform encepalopathy (TSE), the possibility for Member States to apply other measures to cases where the approval of those measures by the Commission is based on a favourable risk assessment taking particularly into account the control measures in that Member State, and where those measures offer an equivalent level of protection.
Recital 6, Regulation (EC) No 220/2009 of the European Parliament and of the Council of 11 March 20…
In forcesince 11 Mar 2009